TGFβ pathobiology in the eye

Laboratory Investigation

Volumn 86, Issue 2, 2006, Pages 106-115

  Saika, Shizuya ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Eye; Gene introduction; Gene knockout; Signal transduction; Transforming growth factor ; Wound healing

Indexed keywords

ACTIVIN; ADENOVIRUS VECTOR; OSTEOGENIC PROTEIN 1; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; SMAD PROTEIN;

CATARACT EXTRACTION; CAUSTIC BURN; CELL FUNCTION; CORNEA; CORNEA INJURY; DEVELOPMENTAL DISORDER; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; FIBROSIS; GENE TARGETING; HUMAN; KERATITIS; LENS; LENS EPITHELIUM; MORPHOGENESIS; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; VIRAL GENE THERAPY; WOUND HEALING; ANIMAL; EYE; GENE THERAPY; METABOLISM; PATHOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT;

ANIMALS; CATARACT EXTRACTION; EYE; GENE THERAPY; HUMANS; KERATITIS; PIGMENT EPITHELIUM OF EYE; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 30944439493     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700375     Document Type: Review

References (109)

1. Martin P. Wound healing - aiming for perfect skin regeneration. Science 1997;276:75-81.
2. Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 2005;31:674-686.
3. Klenkler B, Sheardown H. Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology. Exp Eye Res 2004;79:677-688.
4. Grose R, Werner S. Wound-healing studies in transgenic and knockout mice. Mol Biotechnol 2004;28: 147-166.
5. Efron PA, Moldawer LL. Cytokines and wound healing: the role of cytokine and anticytokine therapy in the repair response. J Burn Care Rehabil 2004;25:149-160.
6. Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 2004;85:47-64.
7. Kim IY, Kim MM, Kim SJ. Transforming growth factor-beta: biology and clinical relevance. J Biochem Mol Biol 2005;38:1-8.
8. Rockey DC. Antifibrotic therapy in chronic liver disease. Clin Gastroenterol Hepatol 2005;3:95-107.
9. Saika S. TGF-β signal transduction in corneal wound healing as a therapeutic target. Cornea 2004;23(Suppl):S25-S30.
10. Schiller M, Javelaud D, Mauviel A. TGF-β-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci 2004;35:83-92.
11. Leask A, Abraham DJ. TGF-β signaling and the fibrotic response. FASEB J 2004;18:816-827.
12. Moustakas A, Pardali K, Gaal A, et al. Mechanisms of TGF-β signaling in regulation of cell growth and differentiation. Immunol Lett 2002;82:85-91.
13. Roberts AB, Russo A, Felici A, et al. Smad3: a key player in pathogenetic mechanisms dependent on TGF-β. Ann NY Acad Sci 2003;995:1-10.
14. ten Dijke P, Goumans MJ, Itoh F, et al. Regulation of cell proliferation by Smad proteins. J Cell Physiol 2002;191:1-16.
15. Van Obberghen-Schilling E, Roche NS, Flanders KC, et al. Transforming growth factor β1 positively regulates its own expression in normal and transformed cells. J Biol Chem 1988;263:7741-7746.
16. Holmes A, Abraham DJ, Sa S, et al. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 2001;276:10594-10601.
17. Jampel HD, Roche N, Stark WJ, et al. Transforming growth factor-β in human aqueous humor. Curr Eye Res 1990;9:963-969.
18. Tripathi RC, Li J, Chan WF, et al. Aqueous humor in glaucomatous eyes contains an increased level of TGF-β2. Exp Eye Res 1994;59:723-727.
19. Kokawa N, Sotozono C, Nishida K, et al. High total TGF-β2 levels in normal human tears. Curr Eye Res 1996;15:341-343.
20. Hu DN, McCormick SA, Lin AY, et al. TGF-β2 inhibits growth of uveal melanocytes at physiological concentrations. Exp Eye Res 1998;67:143-150.
21. Wallentin N, Wickstrom K, Lundberg C. Effect of cataract surgery on aqueous TGF-β and lens epithelial cell proliferation. Invest Ophthalmol Vis Sci 1998;39:1410-1418.
22. Chen KH, Harris DL, Joyce NC. TGF-β2 in aqueous humor suppresses S-phase entry in cultured corneal endothelial cells. Invest Ophthalmol Vis Sci 1999;40:2513-2519.
23. Connor Jr TB, Roberts AB, Sporn MB, et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest 1989;83:1661-1666.
24. Picht G, Welge-Luessen U, Grehn F, et al. Transforming growth factor β2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol 2001;239:199-207.
25. Saika S, Miyamoto T, Kawashima Y, et al. Immunolocalization of TGF-β1, -β2, and -β3, and TGF-β receptors in human lens capsules with lens implants. Graefes Arch Clin Exp Ophthalmol 2000;238:283-293.
26. Shi Y, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003;113:685-700.
27. ten Dijke P, Goumans MJ, Itoh F, et al. Regulation of cell proliferation by Smad proteins. J Cell Physiol 2002;191:1-16.
28. Yang X, Letterio JJ, Lechleider RJ, et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J 1999;18:1280-1291.
29. Petritsch C, Beug H, Balmain A, et al. TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Genes Dev 2000;14:3093-3101.
30. Gotzmann J, Huber H, Thallinger C, et al. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-β1 and Ha-Ras: steps towards invasiveness. J Cell Sci 2002;115:1189-1202.
31. Peron P, Rahmani M, Zagar Y, et al. Potentiation of Smad transactivation by Jun proteins during a combined treatment with epidermal growth factor and transforming growth factor-β in rat hepatocytes. Role of phosphatidylinositol 3-kinase-induced AP-1 activation. J Biol Chem 2001;276:10524-10531.
32. Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001;12:27-36.
33. Vadlamudi R, Adam L, Talukder A, et al. Serine phosphorylation of paxillin by heregulin-1: role of p38 mitogen activated protein kinase. Oncogene 1999;18:7253-7264.
34. Mori S, Matsuzaki K, Yoshida K, et al. TGF-β and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions. Oncogene 2000;23:7416-7429.
35. Tahashi Y, Matsuzaki K, Date M, et al. Differential regulation of TGF-β signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 2002;35:49-61.
36. Yoshida K, Matsuzaki K, Mori S, et al. Transforming growth factor-β and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. Am J Pathol 2005;166:1029-1039.
37. Furukawa F, Matsuzaki K, Mori S, et al. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology 2003;38:879-889.
38. Geller SF, Lewis GP, Fisher SK. FGFR1 signaling and AP-1 expression after retinal detachment: reactive Muller and RPE cells. Invest Ophthalmol Vis Sci 2001;42:1363-1369.
39. Yu L, Hebert MC, Zhang Y. TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J 2002;21:3749-3759.
40. Saklatvala J, Dean J, Finch A. Protein kinase cascades in intracellular signalling by interleukin-1 and tumour necrosis factor. Biochem Soc Symp 1999;64:63-77.
41. Yosimichi G, Nakanishi T, Nishida T, et al. CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem 2001;268:6058-6065.
42. Kim JY, Choi JA, Kim TH, et al. Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite. J Cell Physiol 2002;190:29-37.
43. Mori Y, Chen SJ, Varga J. Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta. Exp Cell Res 2000;258:374-383.
44. Shull MM, Doetschman T. Transforming growth factor-beta 1 in reproduction and development. Mol Reprod Dev 1994;39:239-246.
45. Kaartinen V, Voncken JW, Shuler C, et al. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects ofepithelial- mesenchymal interaction. Nat Genet 1995;11:415-421.
46. Proetzel G, Pawlowski SA, Wiles MV, et al. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet 1995;11:409-414.
47. Sanford LP, Ormsby I, Gittenberger-de Groot AC, et al. TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 1997;124:2659-2670.
48. Saika S, Saika S, Liu CY, et al. TGFβ2 in corneal morphogenesis during mouse embryonic development. Dev Biol 2001;240:419-432.
49. Zhao S, Overbeek PA. Elevated TGFβ signaling inhibits ocular vascular development. Dev Biol 2001;237:45-53.
50. Beebe D, Garcia C, Wang X, et al. Contributions by members of the TGFbeta superfamily to lens development. Int J Dev Biol 2004;48:845-856.
51. Yang YC, Piek E, Zavadil J, et al. Hierarchical model of gene regulation by transforming growth factor β. Proc Natl Acad Sci USA 2003;100:10269-10274.
52. Piek E, Ju WJ, Heyer J, et al. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem 2001;276:19945-19953.
53. Flanders KC, Major CD, Arabshahi A, et al. Interference with transforming growth factor-β/Smad3 signaling results in accelerated healing of wounds in previously irradiated skin. Am J Pathol 2003;163:2247-2257.
54. Evans RA, Tian YC, Steadman R, et al. TGF-β1-mediated fibroblast-myofibroblast terminal differentiation - the role of Smad proteins. Exp Cell Res 2003;282:90-100.
55. Roberts AB, Russo A, Felici A, et al. Smad3: a key player in pathogenetic mechanisms dependent on TGF-β. Ann NY Acad Sci 2003;995:1-10.
56. Saika S, Kono-Saika S, Ohnishi Y, et al. Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am J Pathol 2004;16:651-663.
57. Ashcroft GS, Yang X, Glick AB, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999;1:260-266.
58. Denton CP, Zheng B, Evans LA, et al. Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFβ) receptor leads to paradoxical activation of TGFβ signaling pathways with fibrosis in transgenic mice. J Biol Chem 2003;278:25109-25119.
59. Apple DJ, Solomon KD, Tetz MR, et al. Posterior capsule opacification. Surv Ophthalmol 1992;37:73-116.
60. Saika S, Kawashima Y, Miyamoto T, et al. Immunolocalization of prolyl 4-hydroxylase subunits, a-smooth muscle actin, and extracellular matrix components in human lens capsules with lens implants. Exp Eye Res 1998;66:283-294.
61. Saika S, Miyamoto T, Tanaka S, et al. Response of lens epithelial cells to injury: role of lumican in epithelial-mesenchymal transition. Invest Ophthalmol Vis Sci 2003;44:2094-2102.
62. Saika S. Relationship between posterior capsule opacification and intraocular lens biocompatibility. Prog Retin Eye Res 2004;23:283-305.
63. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 1995;154:8-20.
64. Hay ED, Zuk A. Transformations between epithelium and mesenchymae: normal, pathological, and experimentally induced. Am J Kidney Dis 1995;26:678-690.
65. Kang P, Svoboda KK. PI-3 kinase activity is required for epithelial-mesenchymal transformation during palate fusion. Dev Dyn 2002;225:316-321.
66. Masszi A, Di Ciano C, Sirokmany G, et al. Central role for Rho in TGF-β1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol 2003;284:F911-F924.
67. Sato M, Muragaki Y, Saika S, et al. Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003;112:1486-1494.
68. Tomasek J, Gabbiani G, Hinz B, et al. Myofibroblasts and mechanoregulation of connective tissue remodeling. Nat Rev Mol Cell Biol 2002;3:349-463.
69. Saika S, Okada Y, Miyamoto T, et al. Smad translocation and growth suppression in lens epithelial cells by endogenous TGFβ2 during wound repair. Exp Eye Res 2001;76:679-686.
70. Srinivasan Y, Lovicu FJ, Overbeek PA. Lens-specific expression of transforming growth factor β1 in transgenic mice causes anterior subcapsular cataracts. J Clin Invest 1998;101:625-634.
71. Lovicu FJ, McAvoy JW. FGF-induced lens cell proliferation and differentiation is dependent on MAPK (ERK1/2) signalling. Development 2001;128:5075-5084.
72. Saika S, Ikeda K, Yamanaka O, et al. Adenoviral gene transfer of BMP-7, Id2 or Id3 suppresses injury-induced epithelial-mesenchymal transition of lens epithelium in mice. Am J Physiol Cell Physiol 2005 (in press).
73. Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004; 118:277-279.
74. Pastor JC, de la Rua ER, Martin F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res 2002;21:127-144.
75. Bochaton-Piallat ML, Kapetanios AD, Donati G, et al. TGF-β1, TGF-β receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Invest Ophthalmol Vis Sci 2000;41:2336-2342.
76. Casaroli-Marano RP, Pagan R, Vilaro S. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1999;40:2062-2072.
77. Grisanti S, Guidry C. Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci 1995;36:391-405.
78. Lee SC, Kwon OW, Seong GJ, et al. Epitheliomesenchymal transdifferentiation of cultured RPE cells. Ophthalmic Res 2001;33:80-86.
79. Roberts AB, Sporn MB. The transforming growth factors-β In: Sporn MB, Roberts AB (eds). Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors. Springer-Verlag: New York, 1990, pp 419-472.
80. Carrington L, McLeod D, Boulton M. IL-10 and antibodies to TGF-β2 and PDGF inhibit RPE-mediated retinal contraction. Invest Ophthalmol Vis Sci 2000;41:1210-1216.
81. Cassidy L, Barry P, Shaw C, et al. Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol 1998;82:181-185.
82. Choudhury P, Chen W, Hunt RC. Production of platelet-derived growth factor by interleukin-1β and transforming growth factor-β-stimulated retinal pigment epithelial cells leads to contraction of collagen gels. Invest Ophthalmol Vis Sci 1997;38:824-833.
83. Hinton DR, He S, Jin ML, et al. Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy. Eye 2002;16:422-428.
84. Jaffe GJ, Harrison CE, Lui GM, et al. Activin expression by cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1994;35:2924-2931.
85. Taylor LM, Khachigian LM. Induction of platelet-derived growth factor B-chain expression by transforming growth factor-β involves transactivation by Smads. J Biol Chem 2000;275:16709-16716.
86. Saika S, Ikeda K, Yamanaka O, et al. Transient adenoviral gene transfer of Smad7 prevents injury-induced epithelial-mesenchymal transition of lens epithelium in mice. Lab Invest 2004;84:1259-1270.
87. Saika S, Kono-Saika S, Tanaka T, et al. Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab Invest 2004;84:1245-1258.
88. Saika S, Yamanaka O, Ikeda K, et al. Inhibition of p38MAP kinase suppresses fibrotic reaction of retinal pigment epithelial cells. Lab Invest 2005;85:838-850.
89. Imanishi J, Kamiyama K, Iguchi I, et al. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res 2000;19:113-120.
90. Wilson SE, Chen L, Mohan RR, et al. Expression of HGF, KGF, EGF and receptor messenger RNAs following corneal epithelial wounding. Exp Eye Res 1999;68:377-397.
91. Wilson SE, Liu JJ, Mohan RR. Stromal-epithelial interactions in the cornea. Prog Retin Eye Res 1999;18:293-309.
92. Pelton RW, Saxena B, Jones M, et al. Immunohistochemical localization of TGFβ1, TGFβ2, and TGFβ3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 1991;115:1091-1105.
93. Li DQ, Tseng SC. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol 1995;163:61-79.
94. Wilson SE, Schultz GS, Chegini N, et al. Epidermal growth factor, transforming growth factor a, transforming growth factor β, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp Eye Res 1994;59:63-71.
95. Nishida K, Sotozono C, Adachi W, et al. Transforming growth factor-β1, -β2 and -β3 mRNA expression in human cornea. Curr Eye Res 1995;14:235-241.
96. Joyce NC, Zieske JD. Transforming growth factor-β receptor expression in human cornea. Invest Ophthalmol Vis Sci 1997;38:1922-1928.
97. Zieske JD, Hutcheon AEK, Guo X, et al. TGF-β receptor types I and II are differentially expressed during corneal epithelial wound repair. Invest Ophthalmol Vis Sci 2001;42:1465-1471.
98. Saika S, Okada Y, Miyamoto T, et al. Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium. Invest Ophthalmol Vis Sci 2004;45:100-109.
99. Dumon N, Bakin AV, Arteaga CL. Autocrine transforming growth factor-β signaling mediates Smad-independent motility in human cancer cells. J Biol Chem 2003;278:3275-3285.
100. Klekotka PA, Santoro SA, Zutter MM. Alpha 2 integrin subunit cytoplasmic domain-dependent cellular migration requires p38 MAPK. J Biol Chem 2001;276:9503-9511.
101. Li W, Nadelman C, Henry G, et al. The p38-MAPK/ SAPK pathway is required for human keratinocyte migration on dermal collagen. J Invest Dermatol 2001;117:1601-1611.
102. Qi Z, Atsuchi N, Ooshima A, et al. Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA 1999;96:2345-2349.
103. Sakamoto T, Ueno H, Sonoda K, et al. Blockade of TGF-β by in vivo gene transfer of a soluble TGF-β type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis. Gene Therapy 2000;7:1915-1924.
104. Saika S, Ikeda K, Yamanaka O, et al. Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali. Am J Pathol 2005;166:1405-1418.
105. Nakao A, Fujii M, Matsumura R, et al. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 1999;104:5-11.
106. Dooley S, Hamzavi J, Breitkopf K, et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 2003;125:178-191.
107. Hou CC, Wang W, Huang XR, et al. Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. Am J Pathol 2005;166:761-771.
108. Saika S, Miyamoto T, Yamanaka O, et al. Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-κB, in treatment of corneal alkali burns in mice. Am J Pathol 2005;166:1393-1403.
109. Saika S, Ikeda K, Yamanaka O, et al. Therapeutic effects of adenoviral gene transfer of bone morphogenic protein-7 on a corneal alkali injury model in mice. Lab Invest 2005;85:474-486.